Regenics AS completes first tranche of a NOK 54 M private placement to initiate Collex® clinical trials
Regenics raises NOK 20.4 million in new equity, in the first of a total NOK 54 million two-tranche investment, from Nordic Blue hf., a newly formed Icelandic holding company focusing on investments in Blue Economy. OSLO, Norway, Aug. 13, 2024 /PRNewswire/ — Regenics AS, a private Norwegian biotechnology company based in Oslo (the “Company”), today … Read more
